Supporting this contention, we found that patients with metastatic PCa had significantly higher circulating levels of Glo1 and TGF‐β1 and markedly lower levels of MG‐H1, AP and miR‐101 compared with patients bearing non‐metastatic PCa. This evidence concerns the gene TGFB1 and posterior cortical atrophy.